The new inhibitors of dimethylarginine dimethylaminohydrolase (DDAH) have a single amine function simultaneously displaying the same activity as the most potent known inhibitors without the pharmacokinetically disadvantageous zwitterion profile.
Further Information: PDF
Patent- und Verwertungsagentur für die Wissenschaftlichen Einrichtungen in Schleswig-Holstein GmbH (PVA SH)
Phone: +49 (0)431/8009937
Contact
Dr. Alexandra Baumgartner
